Español Deutsch English Become a Fan of our online pharmacy and get 3€. Get Your Discount Code Here.
Search by keyword::
Atención al Cliente
Rss
Confidence Stamp!
compra-con-confianza
News Categories
Most Popular Tags
Bestsellers
Aceptamos Pago Pay Pal
News and Site Information. Prize Draw
Routine mammograms do not reduce deaths from breast cancer
Date: Wednesday 12 February, 2014
Annual mammograms in middle-aged women do not reduce deaths from breast cancer, this test is essentially as good as the physical examination reveals a new retrospective study of 25 years in Canada. Routine mammograms do not reduce deaths from breast cancer


The study, which included nearly 90,000 women aged 40 to 59, is the latest to question the value of routine mammography. The researchers found the same number of women who died of breast cancer at 25 years, regardless of whether or not undergo annual mammograms.

Mammography is performed routinely for early diagnosis of breast cancer in women. But this really questioned whether this screening really saves lives. In some cases, early detection does not necessarily mean that cancer is curable and other treatments work even if the cancer is found in later stages.

Here you have a summary of the original study, which can read the full in the British Medical Journal, entitled: Twenty five year follow-up for breast cancer incidence and mortality of the Canadian National Breast Screening Study: randomized screening trial

Objective To compare breast cancer incidence and mortality up to 25 years in women aged 40-59 who did or did not undergo mammography screening.

Design Follow-up of randomised screening trial by centre coordinators, the study’s central office, and linkage to cancer registries and vital statistics databases.

Setting 15 screening centres in six Canadian provinces,1980-85 (Nova Scotia, Quebec, Ontario, Manitoba, Alberta, and British Columbia).

Participants 89?835 women, aged 40-59, randomly assigned to mammography (five annual mammography screens) or control (no mammography).

Interventions Women aged 40-49 in the mammography arm and all women aged 50-59 in both arms received annual physical breast examinations. Women aged 40-49 in the control arm received a single examination followed by usual care in the community.

Main outcome measure Deaths from breast cancer.

Results During the five year screening period, 666 invasive breast cancers were diagnosed in the mammography arm (n=44?925 participants) and 524 in the controls (n=44?910), and of these, 180 women in the mammography arm and 171 women in the control arm died of breast cancer during the 25 year follow-up period. The overall hazard ratio for death from breast cancer diagnosed during the screening period associated with mammography was 1.05 (95% confidence interval 0.85 to 1.30). The findings for women aged 40-49 and 50-59 were almost identical. During the entire study period, 3250 women in the mammography arm and 3133 in the control arm had a diagnosis of breast cancer, and 500 and 505, respectively, died of breast cancer. Thus the cumulative mortality from breast cancer was similar between women in the mammography arm and in the control arm (hazard ratio 0.99, 95% confidence interval 0.88 to 1.12). After 15 years of follow-up a residual excess of 106 cancers was observed in the mammography arm, attributable to over-diagnosis.

Conclusion Annual mammography in women aged 40-59 does not reduce mortality from breast cancer beyond that of physical examination or usual care when adjuvant therapy for breast cancer is freely available. Overall, 22% (106/484) of screen detected invasive breast cancers were over-diagnosed, representing one over-diagnosed breast cancer for every 424 women who received mammography screening in the trial.

 

Anthony B Miller, professor emeritus1, Claus Wall, data manager, Cornelia J Baines, professor emerita, Ping Sun, statistician, Teresa To, senior scientist, Steven A Narod, professor.



Article Statistics:
Viewed:375

Customer Reviews (0)

No hay comentarios todav�a. S� el primero!

Publicar un comentario nuevo


CAPTCHA ImageCambiar Imagen
Print View Continue
New Products in April
Boots Solei SP Face Sun Cream SPF50+ 50ml by Boots
Boots Solei SP Face Sun Cream SPF50+ 50ml 11.25€
+ Info
Boots Solei SP Mini Sun Spray SPF50+ 50ml by Boots
Boots Solei SP Mini Sun Spray SPF50+ 50ml 9.95€
+ Info
Boots Solei SP Solar Dry Oil Spray SPF50+ 125ml by Boots
Boots Solei SP Solar Dry Oil Spray SPF50+ 125ml 12.75€
+ Info
Repaskids sunscreen SPF50 100ml Children by Sesderma
Repaskids sunscreen SPF50 100ml Children 21.90€
+ Info
Featured Product
Fertilcontrol Easy Ovulation Monitor Device.

Fertilcontrol Easy Ovulation Monitor Device.
39.60€
30.72€
Salises Cream Gel Cream 50ml

Salises Cream Gel Cream 50ml
40.54€
34.49€
Fillderma NANO wrinkle-filling system

Fillderma NANO wrinkle-filling system
77.09€
52.94€
ACGLICOLIC CLASSIC MOISTURIZING GEL CREAM

ACGLICOLIC CLASSIC MOISTURIZING GEL CREAM
39.93€
32.67€
Condro-Aid Forte 60 Caps.

Condro-Aid Forte 60 Caps.
17.05€
12.49€
Trofolastin anti-stretch-mark moisturising cream 250 ml

Trofolastin anti-stretch-mark moisturising cream 250 ml
21.72€
17.97€
Like us Like us Follow us Follow us Watch Us Watch Us Follow us Follow us Join Us Join Us Follow us Follow us
Visa Mastercard Tick icon
Copyright © 2015 Farmacia La Nucia
Powered by osCommerce